Design and synthesis of adamantyl-substituted flavonoid derivatives as anti-inflammatory Nur77 modulators: Compound B7 targets Nur77 and improves LPS-induced inflammation in vitro and in vivo

Mingtao Ao,Jianyu Zhang,Yuqing Qian,Boqun Li,Xiumei Wang,Jun Chen,Yuxiang Zhang,Yin Cao,Yingkun Qiu,Yang Xu,Zhen Wu,Meijuan Fang
DOI: https://doi.org/10.1016/j.bioorg.2022.105645
IF: 5.307
2022-03-01
Bioorganic Chemistry
Abstract:In continuing our study on discovering new Nur77-targeting anti-inflammatory agents with natural skeletons, we combined adamantyl group and hydroxamic acid moiety with flavonoid nucleus, synthesized three series of flavonoid derivatives with a similar structure like CD437, and evaluated their activities against LPS-induced inflammation. Compound B7 was found to be an excellent Nur77 binder (K<sub>d</sub> = 3.55 × 10<sup>-7</sup> M) and a potent inhibitor of inflammation, which significantly decreased the production of cytokines in vitro, such as NO, IL-6, IL-1β, and TNF-α, at concentrations of 1.25, 2.5, and 5 μM. Mechanistically, B7 modulated the colocalization of Nur77 at mitochondria and inhibited the lipopolysaccharides (LPS)-induced inflammation via the blockade of NF-κB activation in a Nur77-dependent manner. Additionally, B7 showed in vivo anti-inflammatory activity in the LPS-induced mice model of acute lung injury (ALI). These data suggest that the Nur77-targeting flavonoid derivatives can be particularly useful for further pharmaceutical development for the treatment of inflammatory diseases such as ALI.
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?